We would love to hear your thoughts about our site and services, please take our survey here.
BB, whoops.
If you actually read the thread you would realise that it was Dave77 who claimed that people on here had cost others money. I was just using his own logic against him, successfully I might add.
So Dave77, you are quite ok with people who bought in at say £1.50 and are down massively because 'if you don't sell you haven't made a loss'. Lovely :)
Dave77, over the last few months, what group of people would have lost more money?
Those that listened to the rampers?
Those that listened to the derampers?
I don't expect you to answer as that would require a level of integrity that you clearly lack.
Absolute rubbish.
This is nothing to do with Trump, it’s to do with the thousands of applications the FDA are trying to get through.
GDR in communication with the president? Laughable.
One semi decent RNS and the crazies are back!
Nothing I have said is crazy.
BGF receive interest for the loan and would not convert anything they didn't want to sell as they would lose out on interest. As they demonstrated with the last batch they converted.
No II picked up significant numbers of BGF shares last time else we would have seen it in an RNS.
You see LTH14 is under the impression that GDR have done nothing wrong so far. That the strategy is so far fine. Talk about having your head in the clouds.
They plan to sell them all 6.7m else they wouldn't have converted. I don't think any one entity bought the last set they offloaded, no reason why it would be any different this time. I can't see any II wanting to load up on GDR right now!
The rise was largely sentiment driven and the market was also going to cautious around Covid based stocks due to the instability of ongoing revenue. The start of vaccine news killed sentiment and brought the Covid stocks back down to reality and I can't see that sentiment ever returning now unless something disastrous happens with the vaccines.
In regards to GDR, they have proven that they can't sell their product in times of huge demand. The market probably see's the need for tests, it just thinks that GDR will play no major part in it and that is probably corrrect. Demand for tests will plateau as vaccines are rolled out and the existing suppliers will be used to service that demand. GDR won't get a look in.
If this doesn't get sales soon, it will fall further I suspect.
LTH14 - if you are referring to the other products as well then the strategy has definitely been flawed. GDR have said themselves that they have been concentrating on the Covid side of things as a priority over the other products. So far the gamble hasn't paid off which means so far our other products have suffered for nothing.
We were very fairly battered as our value was based on the potential during the period where sentiment around testing was at it's peak. We couldn't capitalise on that and now sentiment has shifted to vaccines.
Testing might be around for a long time but we'll be a very small player in this at best.
If at anytime within the next 12 months we can be back up to £1, we will have done very well. Let's hope at least some of the expected news comes through.